Ethinylandrostenediol
Ethinylandrostenediol is a synthetic, orally active androgen and anabolic steroid (AAS) that is used in the treatment of various medical conditions as well as in bodybuilding. It is a derivative of testosterone, modified to enhance its anabolic properties and reduce its androgenicity. Ethinylandrostenediol is known for its ability to promote muscle growth, increase strength, and improve physical performance, making it a substance of interest both in clinical settings and in the athletic community.
Medical Uses[edit | edit source]
Ethinylandrostenediol has been explored for use in treating conditions associated with low levels of testosterone or other androgens. This includes certain forms of anemia, osteoporosis, and chronic wasting conditions such as HIV/AIDS. It may also be used in hormone therapy for transgender men during the process of gender transition.
Mechanism of Action[edit | edit source]
As an androgen and anabolic steroid, ethinylandrostenediol exerts its effects by binding to and activating the androgen receptor (AR). This leads to an increase in AR-dependent mechanisms which are responsible for muscle growth and development. Additionally, it may also exert effects through other pathways, including the modulation of growth hormone secretion and insulin-like growth factor 1 (IGF-1) levels, further contributing to its anabolic effects.
Side Effects[edit | edit source]
Like other AAS, ethinylandrostenediol can have a range of side effects, particularly when used at high doses or for extended periods. These may include liver toxicity, changes in cholesterol levels, increased risk of cardiovascular disease, hormonal imbalances, and changes in mood or behavior. In men, prolonged use can lead to gynecomastia, testicular atrophy, and reduced fertility. In women, it may cause virilization effects such as deepening of the voice, increased body hair, and changes in menstrual cycle.
Legal Status[edit | edit source]
The legal status of ethinylandrostenediol varies by country. In many jurisdictions, it is classified as a controlled substance, which means its use and distribution are restricted to medical applications and it is illegal to use for bodybuilding or performance enhancement.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of ethinylandrostenediol, including its absorption, distribution, metabolism, and excretion, is an important aspect of its use and effects. It is designed to be orally active, which makes it more convenient than steroid compounds that require injection. However, oral administration of AAS can increase the risk of liver damage compared to injectable forms.
Conclusion[edit | edit source]
Ethinylandrostenediol is a potent androgen and anabolic steroid with potential applications in treating a variety of medical conditions as well as in enhancing physical performance and muscle growth. However, its use is accompanied by significant risks and side effects, and it is subject to legal restrictions in many areas. As with any medication or performance-enhancing substance, individuals should consult with a healthcare professional before considering its use.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD